Implementing Pathways to Improve Pediatric Asthma Care

The PIPA Study (Pathways for Improving Pediatric Asthma Care): A Cluster Randomized Trial

Background:

Asthma affects nearly 10% of American children, and is a leading cause of pediatric emergency visits and hospitalizations. Clinical pathways are operational versions of practice guidelines aimed at the hospital management of common illnesses. Single-site studies of pediatric asthma pathways have shown significant improvements in quality of care.

Primary Objective:

To evaluate the effectiveness of clinical pathways for improving quality of care for children with asthma in a diverse, national sample of emergency department (ED) and hospital settings.

Primary Endpoints:

1. Emergency Department: The proportion of eligible children who receive systemic steroids within 60 minutes of ED arrival
2. Inpatient/Hospital: Mean length of hospital stay

Study Design:

This project will be implemented through an established quality improvement collaborative of hospitals across the United States, the Value in Inpatient Pediatrics Network (part of the American Academy of Pediatrics). A cluster randomized design will be employed. Group 1 hospitals will receive a multifaceted implementation strategy that includes: 1) a pathway implementation toolkit, 2) local multidisciplinary champions in the ED and inpatient settings, 3) audit and feedback, 4) educational seminars, and 5) practice facilitation (via teleconference). Group 2 will receive the same intervention with the addition of a mobile app pathway tool.

Participant/Local champion Eligibility Criteria:

Inclusion Criteria:

• Working as a physician at the study site

Exclusion Criteria:

• None

Patient/child eligibility criteria:

Inclusion Criteria:

• Age 2-17 years
• Primary diagnosis of asthma

Exclusion Criteria:

• Transferred in from another inpatient facility
• Presence of a chronic medical condition that precludes pathway use